ATC Group: A05AX Other drugs for bile therapy

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of A05AX in the ATC hierarchy

Level
Code
Title
1
Alimentary tract and metabolism
2
Bile and liver therapy
3
Bile therapy
4
A05AX
Other drugs for bile therapy

Group A05AX contents

Code
Title
Piprozolin
Hymecromone
Cyclobutyrol

Active ingredients in A05AX

Active Ingredient
Description

Maralixibat is a minimally absorbed, reversible, potent, selective inhibitor of the ileal bile acid transporter (IBAT). Maralixibat acts locally in the distal ileum to decrease the reuptake of bile acids and increase the clearance of bile acids through the colon, reducing the concentration of bile acids in the serum.

Odevixibat is a reversible, potent, selective inhibitor of the ileal bile acid transporter (IBAT). Pharmacodynamic effects odevixibat acts locally in the distal ileum to decrease the reuptake of bile acids and increase the clearance of bile acids through the colon, reducing the concentration of bile acids in the serum.

Related product monographs

Title
Information Source
Document Type
 
European Medicines Agency (EU)
Summary of Product Characteristics (SPC)
European Medicines Agency (EU)
Summary of Product Characteristics (SPC)